U.S. flag

An official website of the United States government

NM_000069.3(CACNA1S):c.1720G>A (p.Ala574Thr) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Apr 1, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003325600.11

Allele description [Variation Report for NM_000069.3(CACNA1S):c.1720G>A (p.Ala574Thr)]

NM_000069.3(CACNA1S):c.1720G>A (p.Ala574Thr)

Gene:
CACNA1S:calcium voltage-gated channel subunit alpha1 S [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q32.1
Genomic location:
Preferred name:
NM_000069.3(CACNA1S):c.1720G>A (p.Ala574Thr)
HGVS:
  • NC_000001.11:g.201077027C>T
  • NG_009816.2:g.40540G>A
  • NM_000069.3:c.1720G>AMANE SELECT
  • NP_000060.2:p.Ala574Thr
  • NC_000001.10:g.201046155C>T
  • NM_000069.2:c.1720G>A
Protein change:
A574T
Molecular consequence:
  • NM_000069.3:c.1720G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004031773GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Mar 1, 2023)
germlineclinical testing

Citation Link,

SCV004125282CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Apr 1, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV004031773.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

In silico analysis supports that this missense variant does not alter protein structure/function; Previously reported in an individual from a cohort of patients with epilepsy and sudden unexplained death; however additional clinical information and segregation data was not provided (Salfati et al., 2019); This variant is associated with the following publications: (PMID: 31847883)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004125282.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

CACNA1S: PM2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 20, 2024